Article
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
PloS one - 1 Jan 2011
Lee Tai-Sung, Kantarjian Hagop, Ma Wanlong, Yeh Chen-Hsiung, Giles Francis, Albitar Maher
Abstract excerpt
BACKGROUND: Mutations in the thrombopoietin receptor (MPL) may activate relevant pathways and lead to chronic myeloproliferative neoplasms (MPNs). The mechanisms of MPL activation remain elusive because of a lack of experimental structures. Modern computational biology techniques were utilized to explore the mechanisms of MPL protein activation due to various mutations. RESULTS: Transmembrane (TM) domain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
